There is a hint of a benefit of pulse oximetry screening as an add-on test to existing standard examinations for detection of critical congenital heart defects in newborns: More cases are detected by additional screening than by the two clinical examinations U1 and U2 alone. This means that newborns can be treated at an early stage and may be protected from severe late complications.